Stay updated on GI-101 in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GI-101 in Advanced Solid Tumors Clinical Trial page.

Latest updates to the GI-101 in Advanced Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe history section now shows Revision: v3.5.5, indicating a new version entry for the page. The previous entry, v3.5.4, is no longer the latest.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision (v3.5.4) was added to the study's Record History, including updates to the Study Status and the addition of Contacts/Locations; an earlier revision (v3.5.3) appears to have been removed from the history.SummaryDifference0.5%

- Check48 days agoChange DetectedThe page footer’s software/version indicator was updated from “v3.5.0” to “v3.5.3,” reflecting a site revision rather than a change to the trial record itself.SummaryDifference0.1%

- Check84 days agoChange DetectedThe study title was updated to GI-101/GI-101A with Pembrolizumab or Lenvatinib in Advanced Solid Tumors, and multiple sections were added/updated, replacing the previous GI-101 title that included Local Radiotherapy.SummaryDifference1%

- Check98 days agoChange DetectedThe record history now shows Revision: v3.4.3 added and Revision: v3.4.2 removed.SummaryDifference0.1%

- Check120 days agoChange DetectedRevision history now includes a new entry for v3.4.2 and removes v3.4.1. This update reflects metadata changes to the Record History and does not affect study data or user-facing functionality.SummaryDifference0.1%

Stay in the know with updates to GI-101 in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GI-101 in Advanced Solid Tumors Clinical Trial page.